U.S. Hospitality Stock News

Wondering whether United Parks & Resorts at around US$37.49 is a bargain or a value trap right now? This article walks through what the current price might be telling you about the stock. The share price is up 5.3% over the last month and 3.5% year to date, but that sits against a 27.6% decline over the last year and a 40.2% decline over three years, which may have shifted how investors see both risk and potential reward. Recent coverage around United Parks & Resorts has highlighted the...

National Bankshares (NKSH) just wrapped up FY 2025 with fourth quarter total revenue of US$15.9 million and basic EPS of US$0.92, alongside net income of US$5.9 million. Trailing twelve month figures show revenue of US$55.6 million and EPS of US$2.49. Over the last few quarters, revenue has gone from US$12.3 million in Q4 2024 to US$15.9 million in Q4 2025, with basic EPS shifting from US$0.48 to US$0.92 across the same period. Trailing EPS moved from US$1.24 to US$2.49 as net profit margin...

Investar Holding (ISTR) has wrapped up FY 2025 with fourth quarter revenue of US$23.5 million and EPS of US$0.55, set against trailing twelve month revenue of US$93.6 million and EPS of US$2.22 that point to a solidly profitable year. The company has seen revenue move from US$86.3 million and EPS of US$2.06 on a trailing basis at the end of Q4 2024 to US$93.6 million and EPS of US$2.22 by Q4 2025, with net profit margin over the last year at 24.5% compared to 23.5% previously. With earnings...

iQIYI (IQ) is back on traders’ radar after the immediate resignation of long-time CFO Jun Wang, the appointment of interim finance head Ying Zeng, and new headlines on content performance and international viewership. See our latest analysis for iQIYI. The CFO change and strong content headlines have arrived after a mixed run for shareholders, with a 7 day share price return of 4.9% and a 1 month share price return of 7.1%, but a 1 year total shareholder return decline of 8.7% and a 5 year...

Bar Harbor Bankshares (BHB) just closed out FY 2025 with fourth quarter total revenue of US$48.2 million and basic EPS of US$0.70, supported by net income of US$11.8 million, while trailing twelve month figures show revenue of US$163.4 million and EPS of US$2.32. Over recent periods, quarterly revenue has moved from US$38.4 million in Q3 2024 to US$37.4 million in Q4 2024, then to US$37.3 million in Q1 2025 and US$44.0 million in Q3 2025 before reaching US$48.2 million in Q4 2025, as EPS...

Crinetics Pharmaceuticals has begun dosing pediatric patients in its Phase 2/3 BALANCE-CAH trial of atumelnant for classic congenital adrenal hyperplasia. Atumelnant is described as a first in class oral ACTH receptor antagonist and is currently the only small molecule in late stage development targeting this mechanism. The program received FDA Orphan Drug Designation for classic congenital adrenal hyperplasia, highlighting the focus on a rare pediatric condition with significant unmet...

BayCom (BCML) has wrapped up FY 2025 with fourth quarter total revenue of US$25.6 million and basic EPS of US$0.63, while trailing twelve month revenue came in at US$96.5 million with EPS of US$2.18. The company has seen revenue move from US$96.3 million and EPS of US$2.10 on a trailing basis at FY 2024 to the latest trailing totals of US$96.5 million and EPS of US$2.18. This sets the backdrop for investors to weigh consistent profitability against how margins might evolve from here. See our...

Heritage Commerce (HTBK) has just wrapped up FY 2025 with fourth quarter revenue of US$53.0 million and basic EPS of US$0.25, alongside trailing twelve month revenue of US$195.6 million and EPS of US$0.78 that reflect the latest run rate. The company has seen revenue move from US$170.3 million to US$195.6 million on a trailing basis, while EPS shifted from US$0.66 to US$0.78. This sets up a picture in which firmer earnings and slightly higher net profit margins are central to how investors...

South Atlantic Bancshares (SABK) has just wrapped up FY 2025 with fourth quarter total revenue of US$15.9 million and basic EPS of US$0.64, supported by net income of US$4.8 million. Over the past year, the company has seen total revenue move from US$13.4 million in Q4 2024 to US$15.9 million in Q4 2025, while trailing twelve month EPS stepped up from US$1.33 to US$2.15, setting the backdrop for reported earnings growth of 60.8% and a higher net profit margin of 26.9% versus 20.6% a year...

Webster Financial (WBS) has wrapped up FY 2025 with fourth quarter total revenue of US$704.2 million and basic EPS of US$1.62, capping a trailing twelve months in which revenue reached US$2.7 billion and EPS came in at US$5.98 alongside 32.5% year over year earnings growth. The company has seen quarterly revenue move from US$595.9 million in Q4 2024 to US$704.2 million in Q4 2025, while basic EPS stepped up from US$1.01 to US$1.62 over the same period. This sets the backdrop for investors to...

ACNB (ACNB) has wrapped up FY 2025 with fourth quarter revenue of US$36.6 million and EPS of US$1.04, supported by net income of US$10.8 million. Over the last few quarters, revenue has moved from US$26.6 million in Q4 2024 to US$41.3 million in Q3 2025 before landing at US$36.6 million in Q4 2025, while quarterly EPS has ranged from US$0.77 in Q4 2024 to US$1.43 in Q3 2025 and US$1.04 most recently, setting up a results season in which investors are weighing earnings power against the...

1st Source (SRCE) has just wrapped up FY 2025 with fourth quarter revenue of US$110.1 million and EPS of US$1.69, capping a trailing twelve month run of US$421.2 million in revenue and EPS of US$6.46. Over the past year, revenue has moved from US$374.7 million and EPS of US$5.36 on a trailing basis to US$421.2 million and EPS of US$6.46. Full year net income reached US$158.3 million. With margins now running at 37.6%, the latest numbers describe a bank that is monetizing its franchise...

National HealthCare (NHC) is back on investor radar after reporting 22.67% revenue growth, maintaining a "GREAT" financial health score and announcing a quarterly dividend of $0.64 per share. See our latest analysis for National HealthCare. That stronger backdrop has coincided with a 90 day share price return of 16.7% and a 1 year total shareholder return of 52.59%, suggesting momentum has been building around National HealthCare’s financial updates and dividend profile, even after a modest 1...

Kinder Morgan (KMI) just capped FY 2025 with Q4 revenue of US$4.5 billion and basic EPS of US$0.45, alongside net income of US$996 million, setting a clear marker for its latest reporting stretch. The company has seen quarterly revenue move from US$3.99 billion and EPS of US$0.30 in Q4 2024 to US$4.5 billion and EPS of US$0.45 in Q4 2025, with trailing twelve month EPS at US$1.37 and net income at US$3.1 billion providing a fuller earnings picture. With net profit margins highlighted as...

FS Bancorp (FSBW) has wrapped up FY 2025 with fourth quarter revenue of US$36.4 million and basic EPS of US$1.14, alongside trailing twelve month revenue of US$143.1 million and EPS of US$4.35 that reflect the broader earnings picture. Over the past year, the company has seen revenue move from US$139.2 million on a trailing basis in FY 2024 to US$143.1 million in FY 2025, while EPS shifted from US$4.48 to US$4.35, setting a mixed backdrop for the latest numbers. With a net profit margin of...

FS Bancorp (FXLG) has just wrapped up FY 2025 with fourth quarter total revenue of US$13.2 million and basic EPS of US$1.34, set against trailing 12 month EPS of US$5.0 and total revenue of US$50.6 million, alongside earnings growth of 18.8% over the past year. Over recent periods the company has seen quarterly revenue range from US$11.7 million to US$13.2 million and basic EPS move between US$1.01 and US$1.34, with trailing net profit margin running at 40.6% compared with 37.8% the prior...

If you are wondering whether ImmunityBio's share price still makes sense after its recent run, the key question is how the current market price lines up with the underlying valuation. The stock last closed at US$6.45, with returns of 16.8% over 7 days, 201.4% over 30 days, 219.3% year to date and 103.5% over 1 year. This naturally raises questions about both upside potential and risk. Recent news around ImmunityBio has largely focused on its progress in the pharmaceuticals and biotech space...

Customers Bancorp (CUBI) closed FY 2025 with fourth quarter revenue of US$214.6 million and basic EPS of US$2.05, contributing to trailing twelve month EPS of US$6.46 on revenue of US$720.4 million. The company has seen quarterly revenue move from US$150.0 million in Q3 2024 to US$214.6 million in Q4 2025, with basic EPS shifting from US$1.36 to US$2.05 over the same span, which highlights improving net profit margin and a 25.7% earnings lift over the past year for investors focused on...

CSX FY 2025 Results: Headline Numbers and Context CSX (CSX) closed FY 2025 with fourth quarter revenue of US$3,508 million and basic EPS of US$0.39, alongside net income excluding extraordinary items of US$720 million. This sets the tone for how the market will judge the latest move in its earnings profile. Over recent periods, the company has seen quarterly revenue range from US$3,423 million to US$3,587 million, while basic EPS moved between US$0.34 and US$0.44. This gives investors a clear...

TriCo Bancshares (TCBK) just posted fourth quarter FY 2025 revenue of US$106.4 million with EPS of US$1.04, capping a trailing twelve month tally of US$407.1 million in revenue and US$3.72 in EPS. Over the past year, revenue has moved from US$389.2 million to US$407.1 million and EPS from US$3.47 to US$3.72 on a trailing basis, giving you a clearer view of how the top and bottom lines are tracking into this latest print. With a net interest margin running at 4.02% and a cost to income ratio...

Northrim BanCorp (NRIM) has wrapped up FY 2025 with fourth quarter total revenue of US$50.0 million and basic EPS of US$0.56, supported by trailing twelve month revenue of US$208.9 million and EPS of US$2.92 that frame the latest numbers in a fuller context. Over the past year, the company has seen revenue move from US$151.9 million to US$208.9 million on a trailing basis while EPS rose from US$1.68 to US$2.92, giving investors a clearer view of how the top line and per share earnings have...

If you are wondering whether Independent Bank shares still offer value after their recent run, it helps to step back and look at what the market is really pricing in. The stock most recently closed at US$78.32, with returns of 2.4% over 7 days, 3.4% over 30 days, 7.0% year to date, 21.8% over 1 year, 13.4% over 3 years, and 23.1% over 5 years, which gives you a sense of how sentiment has evolved over different time frames. These moves have played out against a backdrop of ongoing sector...

RB Global, Inc. recently declared a quarterly cash dividend of US$0.31 per common share, payable on March 2, 2026 to shareholders of record on February 9, 2026, while also beating third-quarter 2025 earnings and revenue forecasts. Alongside this dividend announcement, an analyst upgrade citing market share gains and new contracts with Suncorp and Direct Line highlights growing confidence in RB Global’s competitive position. We’ll now examine how RB Global’s earnings beat and market share...

AppFolio (NasdaqGM:APPF) has appointed Saori Casey, CFO of Sonos and former Apple executive, to its Board of Directors. The move comes alongside a reduction in the size of AppFolio’s board. Casey brings financial leadership and public company board experience to the property management software provider. AppFolio focuses on cloud software for property management firms, a segment where operators continue to look for ways to digitize workflows, centralize data, and manage growing compliance...